Results for tag: "Chronic Refractory Cough Drug"

The Chronic Refractory Cough Drug market is a subset of the larger Respiratory Drugs market. It is composed of drugs used to treat chronic refractory cough, a condition characterized by persistent coughing that does not respond to conventional treatments. These drugs are typically used in combination with other treatments, such as lifestyle modifications, to reduce the frequency and severity of coughing. Commonly prescribed drugs include anticholinergics, antihistamines, and mucolytics. The Chronic Refractory Cough Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, AstraZeneca, Novartis, Sanofi, and Boehringer Ingelheim. Show Less Read more